DBV Technologies Newsroom

Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)

TipRanksOct 25 09:54

DBV Technologies Is Maintained at Buy by HC Wainwright & Co.

Dow JonesOct 24 17:41

DBV Technologies Analyst Ratings

BenzingaOct 24 17:35

DBV Technologies Analyst Ratings

BenzingaSep 24 22:00

JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $5 Price Target

BenzingaSep 24 21:59

JMP Securities Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $5

Futu NewsSep 24 14:31

JMP Securities Maintains DBV Technologies(DBVT.US) With Buy Rating, Maintains Target Price $5

Futu NewsSep 24 07:31

Buy Rating Affirmed for DBV Technologies on Strong VITESSE Trial Progress and FDA Collaboration

TipRanksSep 24 07:00

Kepler Capital Sticks to Their Buy Rating for DBV Technologies (0QAJ)

TipRanksAug 2 09:54

HC Wainwright & Co. Reiterates Buy on DBV Technologies, Maintains $5 Price Target

BenzingaAug 1 18:38

DBV Technologies Price Target Raised to $5.00/Share From $4.00 by JMP Securities

Dow JonesAug 1 02:25

DBV Technologies Analyst Ratings

BenzingaAug 1 02:15

JMP Securities Maintains Market Outperform on DBV Technologies, Raises Price Target to $5

BenzingaAug 1 02:15

JMP Securities Maintains DBV Technologies(DBVT.US) With Buy Rating, Cuts Target Price to $5

Futu NewsJul 31 13:32

JMP Securities Sticks to Its Buy Rating for DBV Technologies SA – American (DBVT)

TipRanksJul 31 13:12

DBV Technologies Analyst Ratings

BenzingaMay 9 03:25

HC Wainwright & Co. Maintains Buy on DBV Technologies, Lowers Price Target to $5

BenzingaMay 9 03:25

Optimistic Buy Rating for DBV Technologies With Viaskin's Market Potential and Regulatory Prospects

TipRanksMay 8 18:32

Buy Rating Affirmed for DBV Technologies SA Amidst Strong Clinical Progress and Solid Financial Footing

TipRanksMay 8 13:00

Buy Rating Affirmed for DBV Technologies on Viaskin Patch Development and Positive Trial Outcomes

TipRanksMar 8 19:35